-Hiroko Kusuhara Researcher Activity Profile

Research Author Detailed Information 

Hiroko Kusuhara Publication Rate By Year

Hiroko Kusuhara has published 2 paper(s) in 2005, 16 paper(s) in 2007, 7 paper(s) in 2008, for a total of 25 research publications in total.

Hiroko H Kusuhara Author Information

LAST NAME: kusuhara

FIRST NAME: Hiroko

INITIALS: h

AFFILIATION:

Papers

Hiroko Kusuhara's Publication Record

1. Dynamic structures of motor proteins myosin and kinesin, and switch protein troponin as detected by SDSL-ESR. Year Published: 2005
Department of Biology, Graduate School of Science, Osaka University and CREST/JST, 1-1 Machikeneyama-cho, Toyonaka 560-0043.
2. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. Year Published: 2007
Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
3. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Japan, and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
4. Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan.
5. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Year Published: 2007
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
6. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones. Year Published: 2007
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
7. SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers. Year Published: 2007
Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
8. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one). Year Published: 2007
Pharmacokinetics Laboratory, Mitsubishi Pharma Corporation, Chiba, Japan.
9. Effect of excipients on breast cancer resistance protein substrate uptake activity. Year Published: 2007
Department of Pharmaceutics, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo, 142-8501, Japan.
10. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
11. Multiple Human Isoforms of Drug Transporters Contribute to the Hepatic and Renal Transport of Olmesartan, a Selective Antagonist of the Angiotensin II AT1-Receptor. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan. sugiyama@mol.f.u-tokyo.ac.jp.
12. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones. Year Published: 2007
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
13. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
14. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
15. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. Year Published: 2007
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
16. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one). Year Published: 2007
Pharmacokinetics Laboratory, Mitsubishi Pharma Corporation, Chiba, Japan.
17. Effect of excipients on breast cancer resistance protein substrate uptake activity. Year Published: 2007
Department of Pharmaceutics, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo, 142-8501, Japan.
18. P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain Barrier. Year Published: 2008
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. sugiyama@mol.f.u-tokyo.ac.jp.
19. Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta. Year Published: 2008
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, USA.
20. P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Year Published: 2008
The Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, Japan.
21. [Adverse effects of drugs induced by transporter-mediated tissue distribution and elimination] Year Published: 2008
22. Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta. Year Published: 2008
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, USA.
23. P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Year Published: 2008
The Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, Japan.
24. Dynamic structures of motor proteins myosin and kinesin, and switch protein troponin as detected by SDSL-ESR. Year Published: 2005
Department of Biology, Graduate School of Science, Osaka University, 1-1 Machikeneyama-cho, Toyonaka 560-0043, Japan. arata@bio.sci.osaka-u.ac.jp
25. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats. Year Published: 2008
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.